[go: up one dir, main page]

PT98707A - Processo para a preparacao de uma composicao farmaceutica contendo clozapina e um agente eliminador de radicais de preferencia acido ascorbio - Google Patents

Processo para a preparacao de uma composicao farmaceutica contendo clozapina e um agente eliminador de radicais de preferencia acido ascorbio

Info

Publication number
PT98707A
PT98707A PT98707A PT9870791A PT98707A PT 98707 A PT98707 A PT 98707A PT 98707 A PT98707 A PT 98707A PT 9870791 A PT9870791 A PT 9870791A PT 98707 A PT98707 A PT 98707A
Authority
PT
Portugal
Prior art keywords
preparing
pharmaceutical composition
composition containing
ascorbic acid
acid preference
Prior art date
Application number
PT98707A
Other languages
English (en)
Other versions
PT98707B (pt
Inventor
Volker Fischer
Ronald Paul Mason
Original Assignee
Sandoz Sa
Us Commerce
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Sa, Us Commerce filed Critical Sandoz Sa
Publication of PT98707A publication Critical patent/PT98707A/pt
Publication of PT98707B publication Critical patent/PT98707B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PT98707A 1990-08-20 1991-08-19 Processo para a preparacao de uma composicao farmaceutica contendo clozapina e um agente eliminador de radicais de preferencia acido ascorbio PT98707B (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56968990A 1990-08-20 1990-08-20
US71713691A 1991-06-18 1991-06-18

Publications (2)

Publication Number Publication Date
PT98707A true PT98707A (pt) 1992-07-31
PT98707B PT98707B (pt) 1999-01-29

Family

ID=27075116

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98707A PT98707B (pt) 1990-08-20 1991-08-19 Processo para a preparacao de uma composicao farmaceutica contendo clozapina e um agente eliminador de radicais de preferencia acido ascorbio

Country Status (30)

Country Link
US (2) US5312819A (pt)
JP (1) JPH0813745B2 (pt)
KR (1) KR100189349B1 (pt)
AT (1) AT400522B (pt)
AU (1) AU649269B2 (pt)
BE (1) BE1006878A5 (pt)
CA (1) CA2065421A1 (pt)
CH (1) CH684162A5 (pt)
CZ (1) CZ281843B6 (pt)
DE (1) DE4191979T (pt)
DK (1) DK51292D0 (pt)
ES (1) ES2078838B1 (pt)
FI (1) FI913888L (pt)
FR (1) FR2665835B1 (pt)
GB (1) GB2254252B (pt)
GR (1) GR1002188B (pt)
HU (1) HUT60137A (pt)
IE (1) IE66121B1 (pt)
IL (1) IL99224A (pt)
IT (1) IT1251226B (pt)
LU (1) LU88099A1 (pt)
MX (1) MX9100742A (pt)
MY (1) MY107976A (pt)
NL (1) NL9120006A (pt)
NZ (1) NZ239464A (pt)
PT (1) PT98707B (pt)
RU (1) RU2080860C1 (pt)
SE (1) SE9201189D0 (pt)
SK (1) SK279225B6 (pt)
WO (1) WO1992003138A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2935292A (en) * 1991-10-31 1993-06-07 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Prevention of drug-induced agranulocytosis with free radical scavengers
US5538965A (en) * 1993-12-23 1996-07-23 Allelix Biopharmaceuticals Inc. Dopamine receptor ligands
CA2735293A1 (en) * 1995-01-17 1996-07-18 Menuco Corp. Nadh and nadph therapeutic agents for dermal administration
JP3889481B2 (ja) * 1996-08-16 2007-03-07 株式会社カネカ 医薬組成物
ES2258825T3 (es) * 1997-10-27 2006-09-01 Cortex Pharmaceuticals, Inc. Tratamiento de la esquizofrenia con ampakinas y neurolepticos.
US8753675B1 (en) * 2000-01-20 2014-06-17 Raj K. Chopra Reduced form of Coenzyme Q in high bioavailability stable dosage forms and related applications
JP2003026567A (ja) * 2001-05-10 2003-01-29 Kanegafuchi Chem Ind Co Ltd 補酵素ｑを有効成分とする粘膜投与用組成物
NZ527142A (en) * 2003-07-23 2006-03-31 Douglas Pharmaceuticals Ltd A stable suspension formulation
NZ588311A (en) * 2008-07-24 2012-08-31 Handa Pharmaceuticals Llc Stabilized atypical antipsychotic formulation to treat psychiatric conditions
RU2441651C1 (ru) * 2010-12-23 2012-02-10 Маргарита Алексеевна Морозова Способ получения фармацевтической композиции клозапина в виде таблеток и фармацевтическая композиция
RU2610169C2 (ru) 2014-09-11 2017-02-08 Общество С Ограниченной Ответственностью "Валентек" ПРОИЗВОДНЫЕ 7-ФТОРО-8-ХЛОРО-5Н-ДИБЕНЗО[b, е][1, 4]ДИАЗЕПИНА И ИХ ПРИМЕНЕНИЕ

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI50242C (fi) * 1969-07-18 1976-01-12 Thomae Gmbh Dr K Menetelmä valmistaa farmakologisesti aktiivisia uusia diallyyliaminoal kanoyylidibenso- tai pyridobenso-diatsepiineja ja niiden happoadditios uoloja.
US3983234A (en) * 1974-07-04 1976-09-28 Sandoz Ltd. Treatment of dyskinesias
US4028467A (en) * 1975-01-07 1977-06-07 Berger Frank M Analgesic compositions comprising levo-propoxyphene and benzo diazepine and process
GB1498857A (en) * 1975-07-03 1978-01-25 Leo Ab Antidepressant composition
DE3069716D1 (en) * 1979-10-01 1985-01-10 Sandoz Ag Dibenzazepine derivatives, their production and pharmaceutical compositions containing them
US4761411A (en) * 1983-05-18 1988-08-02 Hoechst-Roussel Pharmaceuticals Inc. Dihydrobenzopyrrolobenzodiazepines useful for treating pyschoses
DE3542309A1 (de) * 1985-11-29 1987-06-04 Cardona Federico Dr Medizinisches antioxidativum
US4973586A (en) * 1986-01-16 1990-11-27 Schering Corporation Fused benzazepines, compositions of, and medical use thereof
GB8607684D0 (en) * 1986-03-27 1986-04-30 Ici America Inc Thiazepine compounds
CA1327008C (en) * 1988-01-15 1994-02-15 Walter Merz Anti-psychotic imidazobenzodiazepine
US4996199A (en) * 1988-04-08 1991-02-26 Whitby Research, Inc. Penetration enhancers for transdermal delivery of systemic agents
JP2903318B2 (ja) * 1989-04-04 1999-06-07 日研フード株式会社 抗酸化的ストレス物

Also Published As

Publication number Publication date
AT400522B (de) 1996-01-25
SE9201189L (sv) 1992-04-14
FR2665835B1 (fr) 1995-06-23
DK51292A (da) 1992-04-15
WO1992003138A1 (en) 1992-03-05
GB2254252A (en) 1992-10-07
ITMI912261A1 (it) 1993-02-20
GR910100361A (el) 1992-08-31
ES2078838A1 (es) 1995-12-16
ITMI912261A0 (it) 1991-08-20
FI913888A7 (fi) 1992-02-21
PT98707B (pt) 1999-01-29
NL9120006A (nl) 1992-08-03
US5563134A (en) 1996-10-08
AU649269B2 (en) 1994-05-19
SE9201189D0 (sv) 1992-04-14
CS55092A3 (en) 1992-08-12
HU9201090D0 (en) 1992-06-29
GB9206101D0 (en) 1992-06-24
IE66121B1 (en) 1995-12-13
IE912934A1 (en) 1992-02-26
BE1006878A5 (fr) 1995-01-17
MX9100742A (es) 1992-04-01
RU2080860C1 (ru) 1997-06-10
SK279225B6 (sk) 1998-08-05
IT1251226B (it) 1995-05-05
KR920702225A (ko) 1992-09-03
CA2065421A1 (en) 1992-02-21
CZ281843B6 (cs) 1997-02-12
MY107976A (en) 1996-07-15
LU88099A1 (de) 1992-11-16
NZ239464A (en) 1993-10-26
IL99224A0 (en) 1992-07-15
FR2665835A1 (fr) 1992-02-21
DE4191979T (pt) 1992-10-08
ES2078838B1 (es) 1997-02-01
FI913888L (fi) 1992-02-21
IL99224A (en) 1996-01-31
JPH0813745B2 (ja) 1996-02-14
US5312819A (en) 1994-05-17
GR1002188B (en) 1996-03-13
CH684162A5 (de) 1994-07-29
GB2254252B (en) 1994-06-01
FI913888A0 (fi) 1991-08-16
ATA900491A (de) 1995-06-15
AU8396391A (en) 1992-03-17
JPH05503296A (ja) 1993-06-03
KR100189349B1 (en) 1999-06-01
HUT60137A (en) 1992-08-28
DK51292D0 (da) 1992-04-15

Similar Documents

Publication Publication Date Title
PT96438A (pt) Processo para preparacao de anti-oxidante lipideo-selectivos e de composicoes farmaceuticas que os contem
FI923548A7 (fi) Vaahtoa muodostava koostumus farmaseuttiseen käyttöön, sen käyttö ja h oitomenetelmä
BR9604010A (pt) Composição estável de aplicação tópica contendo o ácido ascórbico e pelo menos um poliol emusão uso em uma composição de aplicação tópica contendo o ácido ascórbico uso da composição processo de tratamento dosmético
PT81969B (pt) Processo para preparacao de 11 beta-fenil-esteroides e de composicoes farmaceuticas que os contem
BR8602466A (pt) Processo para preparar uma composicao contendo agente biologicamente ativo de liberacao lenta e composicao
PT84681B (pt) Processo para a preparacao de carboxamidas heterociclicas e de composicoes farmaceuticas que as contem
PT91287A (pt) Processo de preparacao de derivados do acido indazol-3-carboxilico e de composicoes farmaceuticas que os contem
PT82591B (pt) Processo para a preparacao de derivados do acido ascorbico e de composicoes farmaceuticas que os contem
PT98529A (pt) Processo para a preparacao de derivados de acetamida e de composicoes farmaceuticas que os contem
FI955180A7 (fi) Naftaleenifosfonihappojen ureidojohdannaiset ja menetelmä niiden valmi stamiseksi
PT97437A (pt) Processo de preparacao de derivados de hidrato de carbono e de composicoes farmaceuticas que os contem
PT84790B (pt) Processo de preparacao de derivados de amino-tiazol e de amino-oxazole e de composicoes farmaceuticas contendo-os
PT89655A (pt) Processo para a preparacao de novas lactamas substituidas e de composicoes farmaceuticas que as contem
PT98707A (pt) Processo para a preparacao de uma composicao farmaceutica contendo clozapina e um agente eliminador de radicais de preferencia acido ascorbio
MX9205916A (es) Derivados de acido ciclohexanoacetico, proceso para su preparacion y composicion farmaceutica que los comprende
PT99795A (pt) Processo para a preparacao e novos derivados de piperidinil-benzimidazol e de composicoes farmaceuticas que os contem
PT83495B (pt) Processo para a preparacao de difenilpiperidinas n-substituidas e de composicoes farmaceuticas que as contem
PT91870A (pt) Processo para apreparacao de novas quinoliloxazol-2-onas e de composicoes farmaceuticas que as contem
PT84358B (pt) Processo para a preparacao de naftotiazepinonas e de composicoes farmaceuticas que as contem
PT84187B (pt) Processo para a preparacao de novos derivados da isoquinolina e de composicoes farmaceuticas que os contem
PT82319B (pt) Processo de preparacao de derivados de indeno e de naftaleno e de composicoes farmceuticas que os contem
PT90721A (pt) Processo para a preparacao de compostos de imidazoquinoxalina e de composicoes farmaceuticas que os contem
PT98816A (pt) Processo para a preparacao de tienodiazepinas e de composicoes farmaceuticas que as contem
PT87347A (pt) Method of purifying polydextrose and composition containing same
PT91803A (pt) Processo para a preparacao de novos derivados da 2'-halogenometilideno-, 2'-etenilideno- e 2'-etinil-adenosina e de composicoes farmaceuticas que os contem

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19920319

FG3A Patent granted, date of granting

Effective date: 19981026

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20000430